-
-
-
-
-
-
-
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
-
-
-
-
-
-
-
Salarius Announces Closing of $6.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
-
-
-
-
-
-
Salarius Pharmaceuticals and Aspire Capital Announce a $10.9M Common Stock Purchase Agreement
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

